Back
Insmed, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
43
INSM
Insmed, Inc.
Last Price:
$161.41
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight buying pressure.
Insmed, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 170.93 | Sell |
| 20-day SMA: | 175.87 | Sell |
| 50-day SMA: | 188.91 | Sell |
| 200-day SMA: | 129.4 | Buy |
| 8-day EMA: | 169.64 | Sell |
| 20-day EMA: | 176.09 | Sell |
| 50-day EMA: | 179.02 | Sell |
| 200-day EMA: | 141.53 | Buy |
Insmed, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.1 | Sell |
| Relative Strength Index (14 RSI): | 33.75 | Sell |
| Chaikin Money Flow: | 877901 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (168.53 - 190.71) | Sell |
| Bollinger Bands (100): | (147.48 - 193.36) | Sell |
Insmed, Inc. Technical Analysis
| Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 31 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Insmed, Inc. Stock
Is Insmed, Inc. Stock a Buy?
-
Insmed, Inc. share price is 163.46 while INSM 8-day simple moving average is 170.93, which is a Sell signal.
-
The stock price of INSM is 163.46 while Insmed, Inc. 20-day SMA is 175.87, which makes it a Sell.
-
Insmed, Inc. 50-day simple moving average is 188.91 while INSM share price is 163.46, making it a Sell technically.
-
INSM stock price is 163.46 and Insmed, Inc. 200-day simple moving average is 129.40, creating a Buy signal.
INSM Technical Analysis vs Fundamental Analysis
Sell
43
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy or a Sell?
-
Insmed, Inc. stock is rated a SellThe current Insmed, Inc. [INSM] share price is $163.46. The Score for INSM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Insmed, Inc. Stock Info
Market Cap:
34.9B
Price in USD:
163.46
Share Volume:
2.6M
Insmed, Inc. 52-Week Range
52-Week High:
212.75
52-Week Low:
60.40
Sell
43
Insmed, Inc. (INSM)
is a Sell
Insmed, Inc. Share Price Forecast
-
What is the Insmed, Inc. stock price today?The Insmed, Inc. stock price is 163.46 USD today.
-
Will INSM stock go up or go down?Insmed, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Insmed, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Insmed, Inc. is overvalued.
Is Insmed, Inc. Stock a Buy?
-
Insmed, Inc. share price is 163.46 while INSM 8-day exponential moving average is 169.64, which is a Sell signal.
-
The stock price of INSM is 163.46 while Insmed, Inc. 20-day EMA is 176.09, which makes it a Sell.
-
Insmed, Inc. 50-day exponential moving average is 179.02 while INSM share price is 163.46, making it a Sell technically.
-
INSM stock price is 163.46 and Insmed, Inc. 200-day simple moving average is 141.53, creating a Buy signal.
Fundamental Analysis of Insmed, Inc.
Is Insmed, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.78 per share, and an increase next year of $2.75 per share.
Technical Analysis of Insmed, Inc.
Should I short Insmed, Inc. stock?
-
INSM Moving Average Covergence Divergence (MACD) indicator is -6.1, suggesting Insmed, Inc. is a Sell
-
Insmed, Inc. Relative Strength Index (RSI) is 33.75, which suggest Insmed, Inc. is oversold
-
The Bollinger Bands (25) for Insmed, Inc. is (168.53 - 190.71), which suggest Insmed, Inc. is a Sell
-
The Bollinger Bands (100) for Insmed, Inc. is (147.48 - 193.36), which suggest Insmed, Inc. is a Sell
* Insmed, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.